7Baggers
 xortx therapeutics files to sell up to 4.76m shares  MSN Sat, 27 Sep 2025 10:53:39 GMT
 XORTX Therapeutics files to sell up to 4.76M shares  MSN Thu, 25 Sep 2025 20:51:05 GMT
 published on: 2025-09-16 22:00:24  newser.com Wed, 17 Sep 2025 03:00:24 GMT
 published on: 2025-09-14 12:13:16  newser.com Sun, 14 Sep 2025 17:13:16 GMT
 published on: 2025-09-14 06:21:14  newser.com Sun, 14 Sep 2025 11:21:14 GMT
 published on: 2025-09-12 12:52:08  Newser Fri, 12 Sep 2025 17:52:08 GMT
 published on: 2025-09-12 01:56:47  Newser Fri, 12 Sep 2025 06:56:47 GMT
 published on: 2025-09-11 15:31:16  Newser Thu, 11 Sep 2025 20:31:16 GMT
 published on: 2025-09-11 03:30:31  Newser Thu, 11 Sep 2025 08:30:31 GMT
 published on: 2025-09-10 00:06:40  Newser Wed, 10 Sep 2025 05:06:40 GMT
 published on: 2025-09-09 06:05:05  Newser Tue, 09 Sep 2025 11:05:05 GMT
 published on: 2025-09-08 05:26:46  Newser Mon, 08 Sep 2025 10:26:46 GMT
 published on: 2025-09-05 18:19:26  Newser Fri, 05 Sep 2025 23:19:26 GMT
 published on: 2025-09-03 02:34:49  Newser Wed, 03 Sep 2025 07:34:49 GMT
 XORTX Initiates IND Preparation for XORLO™ in Gout Program  GlobeNewswire Wed, 03 Sep 2025 07:00:00 GMT
 XORTX Advances Gout Treatment Program with IND Preparation  TipRanks Wed, 03 Sep 2025 07:00:00 GMT

XORTX Therapeutics
(NASDAQ:XRTX) 

XRTX stock logo

XORTX Therapeutics Inc., a bio-pharmaceutical company, engages in the development and commercialization of therapies to treat progressive kidney diseases, hypertension, insulin resistance, and diabetic nephropathy. It develops XRx-008, a late clinical stage program therapy for autosomal dominant pol...

Founded: 2011
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends